Skip to content

Search

Showing results for "clinical trials"

Researchers unlock key to slowing leukaemia progression in kids

When three-year-old Flo Parker injured her hip on a camping trip five years ago, her parents thought it would be nothing more than a common childhood injury.

Australia’s first regenerative and genetic medicine program for children’s lung disease

A new program that uses cutting edge stem cell techniques to repair lung damage in children will be established at The Kids Research Institute Australia with support from the Telethon-Perth Children’s Hospital Research Fund (TPCHRF).

New national guideline set to tackle skin infections

When health organisations in the north-west of WA requested urgent action to address the region’s high rate of skin infections, Dr Asha Bowen answered the call.

ORIGINS Project shines light on Early Childhood Development

A collaboration between The Kids Research Institute Australia and Joondalup Health Campus is poised to be a game-changer for early childhood development.

Bone density treatment found to slow the progression of leukaemia

The Kids Research Institute Australia researchers may have unlocked a vital key to reducing the progression of leukaemia in children, potentially prompting a change in thinking around the best way to target treatment.

The Kids Research Institute Australia and Alleasing sign agreement worth up to $12.0 million

The Kids Research Institute Australia has signed a three-year extendable strategic supply partnership with leading asset finance and leasing solutions provider Alleasing.

Celebrating 25 years

As our Founding Director Fiona Stanley puts it, The Kids Research Institute Australia was formed on a "wing and a prayer".

ARIEL study

This study will test the hypothesis that the mechanisms of childhood asthma begin in the respiratory tract as early as birth.

The CIRCA DIEM Sub-Studies

A sub-study is an ‘add-on’ study that helps to answer specific questions within a larger research project. If you decide to participate in the CIRCA DIEM study, you or your child may be invited to take part in one of the CIRCA DIEM sub-studies.

CRISPR gene editing and stem cell disease modelling: a new path to genetic and rare disease patient diagnosis

Vanessa Timo Fear Lassmann BSc (Hons), PhD BSc (Hons) MSc PhD Head, Translational Genetics Team Feilman Fellow; Head, Precision Health Research and